Peter Wijngaard Hepion Pharmaceuticals, Inc. (HEPA) insider trading activity

HEPA Quotes by TradingView

Peter Wijngaard is Director of Hepion Pharmaceuticals, Inc.. Currently has a direct ownership of 9,501 shares of HEPA, which is worth approximately $6,460. The most recent transaction as insider was on Nov 27, 2023, when has been sold 2,500 shares (Common Stock) at a price of $3.05 per share, resulting in proceeds of $7,625. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 9.5K
0% 3M change
0% 12M change
Total Value Held $6,460

Peter Wijngaard Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 27 2023
BUY
Open market or private purchase
$7,625 $3.05 p/Share
2,500 Added 20.83%
9,501 Common Stock
Nov 24 2023
BUY
Open market or private purchase
$7,725 $3.09 p/Share
2,500 Added 26.31%
7,001 Common Stock
Sep 19 2023
BUY
Open market or private purchase
$5,640 $5.64 p/Share
1,000 Added 18.18%
4,501 Common Stock
Sep 15 2023
BUY
Open market or private purchase
$11,100 $5.55 p/Share
2,000 Added 36.36%
3,501 Common Stock
Feb 16 2021
BUY
Open market or private purchase
$22,000 $2.2 p/Share
10,000 Added 25.0%
30,000 Common Stock
Dec 18 2020
BUY
Open market or private purchase
$38,200 $1.91 p/Share
20,000 Added 50.0%
20,000 Common Stock
PW

Peter Wijngaard

Director
Edison, NJ

Track Institutional and Insider Activities on HEPA

Follow Hepion Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HEPA shares.

Notify only if

Insider Trading

Get notified when an Hepion Pharmaceuticals, Inc. insider buys or sells HEPA shares.

Notify only if

News

Receive news related to Hepion Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on HEPA